Category: Payer

CMS Considers Alternate Payment Models To Curb Costs On High-Price Treatments, Gene Therapy

“We are trying to do whatever we can to increase competition and give the (health insurance) plans more tools so that they can be better negotiators on our behalf,” Centers for Medicare and Medicaid Services chief Seema Verma tells Reuters. In other CMS news: The agency officially ends two mandatory bundled-payment models and Verma also comments on 1332 waivers.

Payers Weigh the Implications of Multigene Testing Coverage in New UCSF Study

FORT WASHINGTON, Pa., Feb. 15, 2017 /PRNewswire-USNewswire/ — Innovation in precision medicine has introduced an amalgam of testing options, of which hereditary cancer panels—multigene tests—are a major component. Additionally, the importance of inherited cancer genomics was further…